BioCentury
ARTICLE | Company News

United Therapeutics submits UT-15 MAA

February 5, 2001 8:00 AM UTC

UTHR submitted an MAA in France for its Remodulin ( UT-15) prostacyclin analog to treat pulmonary arterial hypertension. Remodulin, which was formerly known as Uniprost, is also under review in the U....